Sign up today for the industry's No. 1 market access intelligence briefing 

3x times per week, brought to you by the global experts at Analytica Laser 

Relevant data at your fingertips


With the Radar you're always up to date via one crisp m0rning briefing in your inbox - without wasting time browsing through dozens of websites and news sources every day

Latest reimbursement recommendations and info on financing from public funds announced by HTA & Gov. agencies

Information on key changes in legal provisions regulating financing of health technologies from public funds

News on drug safety, new marketing authorizations, variations in registered and reimbursed indications, and more


Intelligence you can count on



Sources screened today


Markets covered


Expert Reviewers


Defined Items 

What is Market Access Radar about?

Timely Updates - Critical Information - Global Reach

Market Access Radar provides commercial and clinical development specialists with timely, relevant news pertaining to market access for drugs and medical devices in the US, Canada, the EU5, CEE countries, Australia and New Zealand. This information includes new or updated reimbursement recommendations, financing and legal changes, marketing authorizations, safety records, clinical trial milestones and other important events.

A team of experienced Analytica Laser market access professionals assesses and prioritizes the information’s impact prior to its selection. This approach ensures that the most critical market access information is included, offering decision value for subscribers.


Dr. Jacek Walczak

VP, Analytica Laser &

Lead, Market Access Radar

"The Radar is much more than just a newsletter - it’s an all-in-one hub for the key information that is critical to market access & HTA decision-making"


Sign up for free


Register today for your personal market access briefings, vetted by 95+ Analytica Laser experts working across 25+  pharma markets globally 

© 2018 by Analytica Laser, a Certara Company

Contact & Support

Call  +44 20 3137 5800  /  or +1 212 686 4100